Stock Analysis on Net

Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

Thermo Fisher Scientific Inc., common-size consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

Microsoft Excel
Sep 27, 2025 Jun 28, 2025 Mar 29, 2025 Dec 31, 2024 Sep 28, 2024 Jun 29, 2024 Mar 30, 2024 Dec 31, 2023 Sep 30, 2023 Jul 1, 2023 Apr 1, 2023 Dec 31, 2022 Oct 1, 2022 Jul 2, 2022 Apr 2, 2022 Dec 31, 2021 Oct 2, 2021 Jul 3, 2021 Apr 3, 2021 Dec 31, 2020 Sep 26, 2020 Jun 27, 2020 Mar 28, 2020
Short-term obligations and current maturities of long-term obligations 3.71 2.19 2.85 2.27 4.10 5.20 4.58 3.66 4.94 5.12 6.47 5.74 1.12 1.12 2.01 2.67 0.03 0.01 0.01 3.81 0.00 1.10 1.26
Accounts payable 3.03 2.94 3.08 3.16 2.60 2.59 2.63 2.91 2.58 2.57 2.96 3.48 2.73 2.85 2.88 3.01 3.13 3.10 3.25 3.15 2.66 2.25 2.72
Accrued payroll and employee benefits 1.83 1.50 1.43 2.04 1.82 1.52 1.35 1.62 1.50 1.39 1.38 2.16 2.06 1.90 1.76 2.55 2.47 2.20 1.99 2.77 2.40 1.92 1.29
Contract liabilities 2.77 2.77 2.89 2.93 2.65 2.63 2.71 2.72 2.62 2.75 2.81 2.68 2.84 3.01 3.10 2.79 1.96 2.17 2.12 1.84 1.63 1.58 1.60
Other accrued expenses 3.11 3.16 3.05 3.29 3.38 3.06 3.07 3.29 2.93 3.16 3.16 3.45 3.54 3.26 3.27 3.10 2.96 2.75 3.24 3.35 3.03 2.91 2.50
Current liabilities 14.45% 12.56% 13.30% 13.70% 14.55% 15.00% 14.35% 14.19% 14.59% 15.00% 16.78% 17.51% 12.28% 12.14% 13.01% 14.12% 10.53% 10.23% 10.61% 14.92% 9.72% 9.76% 9.37%
Deferred income taxes 0.82 0.62 1.05 1.30 1.12 1.54 1.87 1.95 2.70 3.02 3.14 2.93 3.47 3.67 3.77 4.03 1.99 2.41 2.86 2.60 2.39 2.84 3.64
Other long-term liabilities 4.15 4.22 4.01 4.10 4.33 4.46 4.70 4.70 4.46 4.30 4.47 4.36 4.86 5.01 5.03 4.77 5.41 5.19 5.08 4.84 5.29 5.39 5.56
Long-term obligations, excluding current maturities 30.92 32.61 31.67 29.86 31.08 30.75 32.09 31.71 31.41 31.02 30.78 29.76 31.09 32.29 33.84 33.99 29.47 27.73 28.27 27.67 32.92 33.51 32.77
Long-term liabilities 35.89% 37.45% 36.73% 35.26% 36.53% 36.74% 38.66% 38.36% 38.57% 38.34% 38.39% 37.05% 39.42% 40.97% 42.64% 42.80% 36.87% 35.33% 36.22% 35.11% 40.60% 41.73% 41.97%
Total liabilities 50.35% 50.01% 50.04% 48.96% 51.08% 51.74% 53.01% 52.55% 53.16% 53.33% 55.17% 54.56% 51.70% 53.11% 55.65% 56.92% 47.40% 45.56% 46.83% 50.03% 50.32% 51.50% 51.34%
Redeemable noncontrolling interest 0.13 0.12 0.13 0.12 0.13 0.12 0.12 0.12 0.12 0.12 0.13 0.12 0.13 0.13 0.12 0.13 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Preferred stock, $100 par value; none issued 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Common stock, $1 par value 0.43 0.44 0.45 0.46 0.44 0.45 0.46 0.45 0.46 0.47 0.47 0.45 0.49 0.49 0.47 0.46 0.60 0.65 0.66 0.63 0.68 0.71 0.74
Capital in excess of par value 17.79 18.01 18.29 18.46 17.77 17.92 18.01 17.51 17.69 18.10 17.84 17.23 18.33 18.18 17.57 17.00 21.68 23.38 23.79 22.56 24.14 24.90 25.88
Retained earnings 55.67 55.22 54.97 54.56 51.23 50.70 49.99 47.98 47.26 47.06 45.49 43.14 44.68 43.14 40.46 37.25 46.03 47.38 46.03 40.72 40.13 38.74 38.83
Treasury stock at cost -21.66 -21.01 -21.47 -19.76 -18.16 -18.46 -18.73 -15.33 -15.58 -16.03 -15.93 -12.37 -12.16 -12.10 -11.82 -9.38 -12.11 -13.08 -13.43 -9.87 -10.64 -10.99 -11.53
Accumulated other comprehensive loss -2.72 -2.76 -2.37 -2.77 -2.47 -2.45 -2.85 -3.27 -3.12 -3.11 -3.23 -3.19 -3.23 -3.01 -2.53 -2.45 -3.61 -3.88 -3.89 -4.07 -4.64 -4.85 -5.26
Total Thermo Fisher Scientific Inc. shareholders’ equity 49.52% 49.90% 49.87% 50.95% 48.81% 48.16% 46.88% 47.34% 46.70% 46.49% 44.64% 45.27% 48.10% 46.69% 44.16% 42.88% 52.60% 54.44% 53.17% 49.97% 49.68% 48.50% 48.66%
Noncontrolling interests 0.01 -0.04 -0.03 -0.03 -0.02 -0.01 -0.01 -0.01 0.02 0.05 0.06 0.06 0.07 0.07 0.07 0.07 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total equity 49.53% 49.86% 49.83% 50.92% 48.79% 48.14% 46.87% 47.33% 46.72% 46.55% 44.70% 45.32% 48.17% 46.76% 44.23% 42.95% 52.60% 54.44% 53.17% 49.97% 49.68% 48.50% 48.66%
Total liabilities, redeemable noncontrolling interest and equity 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 10-Q (reporting date: 2025-09-27), 10-Q (reporting date: 2025-06-28), 10-Q (reporting date: 2025-03-29), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-28), 10-Q (reporting date: 2024-06-29), 10-Q (reporting date: 2024-03-30), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-07-01), 10-Q (reporting date: 2023-04-01), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-10-01), 10-Q (reporting date: 2022-07-02), 10-Q (reporting date: 2022-04-02), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-10-02), 10-Q (reporting date: 2021-07-03), 10-Q (reporting date: 2021-04-03), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-26), 10-Q (reporting date: 2020-06-27), 10-Q (reporting date: 2020-03-28).


The analysis of the financial composition over the periods reveals several notable trends in liabilities and equity proportions relative to the total capital structure.

Current Liabilities:
Current liabilities as a percentage of total liabilities and equity show fluctuations, with a notable increase in the quarter ending December 2020, peaking at approximately 14.92%, followed by a decline and another upward trend reaching around 17.51% in December 2022. More recently, the proportion stabilizes near the mid-teens, suggesting variability in short-term obligations possibly influenced by operational factors or shifts in working capital management.
Short-term Obligations and Current Maturities of Long-term Obligations:
This component exhibits considerable volatility throughout the periods, initially low in early 2020, rising sharply in late 2020 and again around late 2022, reaching as high as approximately 6.47%. Subsequent periods show a fluctuating but generally downward trend. This variability reflects changes in impending repayments of long-term debt or adjustments in short-term financing strategies.
Accounts Payable:
Accounts payable remain relatively stable, oscillating mildly between approximately 2.25% and 3.25%, indicating consistent day-to-day supplier payment obligations without significant spikes or reductions over the observed timeline.
Accrued Payroll and Employee Benefits:
There is a moderate variability with an increase seen in mid-2020 peaking near 2.77%, followed by declines and minor rebounds, settling around a range of 1.35% to 2.04% more recently. This pattern may correspond to headcount changes, payroll timing, or benefit accrual practices.
Contract Liabilities:
Contract liabilities show a general increasing trend through 2021 and early 2022, peaking above 3%, before moderating somewhat yet maintaining a level close to just under 3%, indicating sustained deferred revenue or prepayments from customers.
Other Accrued Expenses:
These expenses show minor fluctuations but maintain a steady range between approximately 2.5% and 3.5%, suggesting relatively stable other accrued cost structures relative to overall liabilities and equity.
Deferred Income Taxes:
Deferred taxes decline notably over the entire timeframe from around 3.6% in early 2020 to below 1% by mid-2025. This consistent decrease points to ongoing utilization of deferred tax balances or favorable tax planning impacts reducing deferred tax liabilities relative to the capital base.
Long-term Obligations:
Long-term obligations, excluding current maturities, form a significant and relatively stable portion of the capital structure, fluctuating around 30% to 34%, although a dip is registered in late 2020 with a recovery through 2021 and subsequent slight declines. The stability in this range reflects sustained long-term financing exposure aligned with the company's strategic funding approach.
Other Long-term Liabilities:
These liabilities remain stable around 4% to 5.5%, suggesting consistent long-term obligations outside of traditional debt, potentially including pension or lease liabilities.
Total Liabilities:
Total liabilities as a percentage of the capital structure maintain a range predominantly between 45% and 57%, with the highest ratios observed in late 2021 and a decreasing trend into 2024 and beyond, indicating a gradual reduction in leverage or growth in equity components at certain points.
Equity Components:
Common Stock and Capital in Excess of Par Value:
Common stock remains a minimal but steady proportion of total capital, typically below 1%. Capital in excess of par value declines notably from nearly 26% in early 2020 to about 17% in recent periods, reflecting potential share repurchases, stock issuances at varying prices, or accounting reclassifications.
Retained Earnings:
Retained earnings display a significant upward trend from approximately 39% to nearly 56% by the last observations, indicating accumulation of earnings reinvested in the business, a positive sign of operational profitability and financial health.
Treasury Stock:
Treasury stock shows increasing negative values reaching roughly -22%, reflecting ongoing share repurchase programs which reduce outstanding equity and thus influence equity ratios upward indirectly by decreasing share count.
Accumulated Other Comprehensive Loss:
This item remains a negative component of equity but shows a trend towards less severe losses, decreasing from approximately -5.3% to a range near -2.3%, suggesting improvement in unrealized losses on investments or foreign currency translation impacts.
Total Shareholders’ Equity:
Total equity fluctuates, with a marked dip around late 2021 (approximately 43%) followed by recovery and gradual increase into the 50% range by 2024 and 2025, underlining a strengthening equity base relative to liabilities.
Noncontrolling Interests and Redeemable Noncontrolling Interest:
These elements remain minimal and relatively stable throughout the periods, contributing insignificantly to the overall capital structure.
Overall Capital Structure:
The company exhibits a balanced capital structure with liabilities and equity each contributing roughly half of the total mix. Over the observed timeline, a slight shift toward enhanced equity proportions is visible, driven by growing retained earnings and consistent share repurchases reducing treasury stock. Meanwhile, liabilities show moderate volatility mostly due to changing current liabilities and deferred tax fluctuations.